Australian Hospitals Miss Possibility to Combat Record Whooping Cough Outbreak
Table of Contents
A critical gap in vaccination protocols is hindering efforts to control a surging whooping cough epidemic in Australia, with hospitals largely failing to offer patients a booster that protects against the highly contagious disease.
Australia is facing an unprecedented outbreak of whooping cough, also known as pertussis, with authorities reporting 80,000 cases in the last two years – an all-time high. A new analysis by the Immunisation Foundation of Australia reveals that a notable number of hospitals are not routinely administering a combined vaccine offering protection against tetanus and whooping cough, despite established health guidelines recommending its use.
Rising Cases and Vulnerable Populations
The current outbreak poses a particularly severe threat to infants and young children, for whom whooping cough can be life-threatening. Often called the “100-day cough” due to its prolonged duration, the bacterial infection attacks the airways, causing severe coughing fits and breathing difficulties. The disease is notably more contagious than both the flu and COVID-19, rapidly spreading through communities.
“It’s unacceptable that so many vaccines used for tetanus in Australian hospitals do not include added protection against whooping cough, despite established national recommendations,” stated a representative from the Immunisation Foundation. The foundation’s founder tragically lost her 32-day-old son, Riley, to the disease a decade ago, fueling her advocacy for improved vaccination practices.
Hospital Stocking discrepancies
The Immunisation Foundation’s probe found a concerning disparity in hospital vaccine stocking practices. Of the 469 hospitals surveyed, 401 were found to be stocking the older diphtheria and tetanus vaccine, which does not offer protection against whooping cough. The combined vaccine, which provides broader immunity, costs only a few dollars more per dose.
Further research indicates that approximately one million adults over the age of 50 have received the older vaccine when seeking tetanus protection, missing the opportunity to together boost their immunity against whooping cough.
Adult Vaccination as a Key Strategy
Experts emphasize the critical role of adult vaccination in curbing the outbreak.”Adults are a large component of the massive pertussis epidemic we’ve seen unfold in Australia, so vaccination of adults is part of the solution,” explained Raina MacIntyre, head of global biosecurity at the Kirby Institute at the University of New South Wales. “Whooping cough is deadly for infants but has also caused serious complications in adults.”
The findings underscore a missed opportunity to leverage routine medical encounters – particularly those involving wound care – to enhance population-wide immunity against this dangerous and increasingly prevalent disease. Addressing this gap in vaccination protocols is crucial to protecting vulnerable populations and mitigating the impact of the ongoing outbreak.
Why is this happening? Australia is experiencing a record-breaking whooping cough outbreak, with 80,000 cases reported in the last two years. A key factor is hospitals primarily stocking the older diphtheria and tetanus vaccine, which doesn’t protect against whooping cough, instead of the combined tetanus-whooping cough vaccine.
Who is affected? The outbreak particularly threatens infants and young children, as whooping cough can be life-threatening for them. Though,adults are also susceptible and contribute to the spread of the disease. Approximately one
